New Key Statistics Module, Z-Score and F-Score
SZSE:002589 Key Ratios
Market Cap ¥ M | 4,273.38 |
Enterprise Value ¥ M | 5,336.04 |
P/E(ttm) | 315.56 |
PE Ratio without NRI | 135.24 |
Forward PE Ratio | -- |
Price/Book | 0.78 |
Price/Sales | 0.55 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 7,980.00 |
EPS (TTM) ¥ | 0.009 |
Beneish M-Score | -2.24 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 51.70 |
EV-to-EBITDA | 51.70 |
PEG | -- |
Shares Outstanding M | 1,504.71 |
Net Margin (%) | 0.18 |
Operating Margin % | -1.58 |
Pre-tax Margin (%) | -1.80 |
Quick Ratio | 0.99 |
Current Ratio | 1.09 |
ROA % (ttm) | 0.08 |
ROE % (ttm) | 0.26 |
ROIC % (ttm) | 0.18 |
Dividend Yield % | -- |
Altman Z-Score | 0.90 |
SZSE:002589 Number of Guru Trades
SZSE:002589 Volume of Guru Trades
Gurus Latest Trades with SZSE:002589
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002589 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Realcan Pharmaceutical Group Co Ltd Insider Transactions
No Available Data